期刊文献+

阿司匹林抵抗的现况研究

Status Study of Aspirin Resistance
下载PDF
导出
摘要 很多心血管疾病患者在进行阿司匹林治疗时效果不佳,也就是产生所谓"阿司匹林抵抗"。通过生化方法测定,可以将阿司匹林抵抗分为三种不同类型,即药代动力学型、药效学型、假抵抗型。实验室检测通过活体评估血小板功能及来自活体的血小板聚集两种途径来评价阿司匹林对血小板的作用。研究发现产生阿司匹林抵抗的因素有很多,而目前的研究方向集中在对单核苷酸多态性的分析研究。 Many patients with cardiovascular disease still would happen cardiovascular disease during treatment with aspirin, which is called "aspirin resistance". By biochemical methods, we divided aspirin resistance into three different types, which are pharmacokinetics, pharmacodynamics, false resistance type. In laboratory, we evaluate the role of aspirin on platelet in two ways,test assessment ofplatelet function in vivo and platelet aggregation. Researchs found that there are many factors relative with the occurence of aspirin resistance, and the research direction of the current research focuse on the analysis of single nucleotide polymorphisms.
作者 耿磊 封启明
出处 《中国医药指南》 2013年第34期65-66,共2页 Guide of China Medicine
关键词 阿司匹林抵抗 检测方法 血小板聚集 基因多态性 Aspirin resistance Detection method Platelet aggregation Gene polymorphism
  • 相关文献

参考文献18

  • 1Cattaneo M. Laboratory detection of'aspirin resistance':what test should we use(if any)[J].{H}EUROPEAN HEART JOURNAL,2007,(14):1673-1675.
  • 2Akay OM,Canturk Z,Akin E. Aspirin-resistance frequency:a prospective study in 280 healthy Turkish volunteers[J].Clin Appl Thromb Hesmost,2009,(01):98-102.
  • 3Shenkman B,Matetsky S,Feper P. Variable responsiveness to clopidogrel and aspirin among patients with acute coronary syndrome as assessed by platelet functions tests[J].{H}Thrombosis research,2008,(03):336-345.
  • 4Snoep JD,Hovens MM,Eikenboom JC. Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events:a systematic review and meta-analysis[J].{H}Archives of Internal Medicine,2007,(15):1593-1599.
  • 5WeberAA,Przy tulskiB,SchanzA,et a. l Towards a de finition of aspir in resistance:a typological approach[J].{H}PLATELETS,2002,(01):37-40.
  • 6Patrono C,Coller B,Dalen JE. Platelet-active drugs.The relationships among dose,effectiveness,and side effects[J].{H}CHEST,200 .39S-63S.
  • 7Postu?a M,Tarchalska-Kryńska B,Krzysztof J. Factors responsible for "aspirin resistance”-can we identify them[J].{H}Kardiologia Polska,2010,(04):403-411.
  • 8Venugopal SK,Devaraj S,Jialal I. C reactive protein decreases prostacyclin rel ease from human aorticendothelial cells[J].{H}CIRCULATION,2003,(14):1676-1678.
  • 9Watala C,Golanski J,Pluta J. "Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid(aspirin)-its relation to metabolic control”[J].{H}Thrombosis research,2004,(02):101-113.
  • 10XU ZH,JIAO JR,YANG R. Aspirin Resistance:Clinical Significance and Genetic Polymorphism[J].{H}Journal of International Medical Research,2012,(01):282-292.

二级参考文献14

  • 1张林,孙子林,周虹.2型糖尿病及其慢性并发症患者血清糖基化终产物和同型半胱氨酸水平的变化[J].中国老年学杂志,2007,27(9):877-878. 被引量:5
  • 2Pulcinelli FM,Biasucci LM,Riondino S,et al.COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment[J].European Heart Journal,2009,30(10):1279-1286.
  • 3Watala C,Golanskij C,Waczulikova L,et al.High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats:a multiparametric aggregation study[J].Blood Coagulation and Fibrinolysis,2006,17(2):113-124.
  • 4Watala C,Pluta J,Golanski J.et al.Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin[J].J Mol Med,2005,83(2):148-158.
  • 5Watala C,Golanski G,Pluta J,et al.Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control[J].Thrombosis Research,2004,113(2):101-113.
  • 6Goldin A,Beckman JA.Advanced glycation end products:sparking the of development diabetic vascular injury[J].Circulation,2006,114(6):597-605.
  • 7Tseng ST,Sheu WH,Lee WJ,et al.Relationship between several surrogate estimates of insulin sensitivity in non-diabetic patients with coronary disease[J].J Formos Med Assoc,2005,104(2):94-110.
  • 8Ferreira IA,Mocking AIM,Feijge MAH,et al.Platelet inhibition by insulin is absent in Type 2 Diabetes Mellitus[J].Arterioscler Thromb Vasc Biol,2006,26(2):417-422.
  • 9Sobel BE,Lee YH,Pratley RE,et al.Increased plasminogen activator inhibitor type-1 (PAI-1) in the heart as a function of age[J].Life Sci,2006,79(17):1600-1605.
  • 10Expert panel on detection,evaluation and treatment of high blood cholesterol in adults.Exeutive summary of the third report of the national cholesterol education program (ncep) expert panel on detection,evaluation,and treatment of high blood cholesterol in adults (adult treatment panel Ⅲ)[J].JAMA,2001,285(19):2486-2497.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部